x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

GI Insights

Looking to digest the latest in gastroenterology? GI Insights is here to provide updates on screening guidelines, diagnostic options, and management tools for all diseases and disorders affecting the gastrointestinal tract.

science & medicine medicine

All Episodes

00:00:00

Addressing the Challenges of Gastroparesis in Patients

GI Insights ·

2023/06/05

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Michael Camilleri, MD Metoclopramide is the only FDA-approved medication for the treatment of gastroparesis; however, it comes with a black box warning. To discuss the challenges in diagnosing and treating gastroparesis, Dr. Peter Buch is joined by Dr. Michael Camilleri, Professor of Medicine, Pharmacology, and Physiology at the Mayo Clinic in Rochester, Minnesota.

en

00:00:00

Addressing the Challenges of Gastroparesis in Patients

GI Insights ·

2023/06/05

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Michael Camilleri, MD Metoclopramide is the only FDA-approved medication for the treatment of gastroparesis; however, it comes with a black box warning. To discuss the challenges in diagnosing and treating gastroparesis, Dr. Peter Buch is joined by Dr. Michael Camilleri, Professor of Medicine, Pharmacology, and Physiology at the Mayo Clinic in Rochester, Minnesota.

en

00:00:00

Uncovering the Complications of Primary Biliary...

GI Insights ·

2023/06/01

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Alan Bonder, MD According to this clinician, the most important thing for primary biliary cholangitis (PBC) patients is the diagnosis, and anyone with abnormal liver tests should be sent an antimitochondrial antibody (AMA). Dive into this interview with host Dr. Peter Buch and Dr. Alan Bonder, Assistant Professor of Medicine and the Medical Director of Liver Transplantation at Beth Israel Medical Center in Boston.

en

00:00:00

Uncovering the Complications of Primary Biliary...

GI Insights ·

2023/06/01

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Alan Bonder, MD According to this clinician, the most important thing for primary biliary cholangitis (PBC) patients is the diagnosis, and anyone with abnormal liver tests should be sent an antimitochondrial antibody (AMA). Dive into this interview with host Dr. Peter Buch and Dr. Alan Bonder, Assistant Professor of Medicine and the Medical Director of Liver Transplantation at Beth Israel Medical Center in Boston.

en

00:00:00

Identifying Individualized Treatment Approaches for...

GI Insights ·

2023/06/01

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE Assessing eosinophilic esophagitis (EOE) patients’ sensitivity to specific foods is key to creating a personalized diet to help treat this disease. So what role does the six-food elimination diet have in EOE patients? Dive in with Dr. Peter Buch as he speaks with Dr. Brooks Cash, Chief of the Division of Gastroenterology, Hepatology, and Nutrition at the University of Texas Health Sciences

en

00:00:00

Identifying Individualized Treatment Approaches for...

GI Insights ·

2023/06/01

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE Assessing eosinophilic esophagitis (EOE) patients’ sensitivity to specific foods is key to creating a personalized diet to help treat this disease. So what role does the six-food elimination diet have in EOE patients? Dive in with Dr. Peter Buch as he speaks with Dr. Brooks Cash, Chief of the Division of Gastroenterology, Hepatology, and Nutrition at the University of Texas Health Sciences

en

00:00:00

Uncovering Unmet Needs in Hepatitis Management

GI Insights ·

2023/05/05

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Paul Kwo, MD Hepatitis B and C are both highly prevalent infections around the world. However, many individuals are not aware of their infection, which can lead to progressive liver damage and other health consequences. This is just one of the many unmet needs in the hepatitis care continuum, and joining Dr. Charles Turck to help uncover those unmet needs and discuss how the latest management strategies can help address them is Dr

en

00:00:00

The Role of Treatments & Endoscopy in the...

GI Insights ·

2023/04/20

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Kunal Jajoo, MD Clinicians should be assessing their patients immediately and trying to understand how quickly they need to provide endoscopy and endoscopic therapy. So in patients with a high risk for thromboembolism, how soon after GI bleeding may anticoagulation be considered? Take a deep dive with Dr. Peter Buch as he speaks with Dr. Kunal Jajoo, Assistant Professor of Medicine at the Brigham and Women’s Hospital of Harvard Medical

en

00:00:00

The Role of Treatments & Endoscopy in the...

GI Insights ·

2023/04/20

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Kunal Jajoo, MD Clinicians should be assessing their patients immediately and trying to understand how quickly they need to provide endoscopy and endoscopic therapy. So in patients with a high risk for thromboembolism, how soon after GI bleeding may anticoagulation be considered? Take a deep dive with Dr. Peter Buch as he speaks with Dr. Kunal Jajoo, Assistant Professor of Medicine at the Brigham and Women’s Hospital of Harvard Medical

en

00:00:00

A Review of Autoimmune Hepatitis in Patients

GI Insights ·

2023/04/19

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Alan Bonder, MD Patients with underlying autoimmune diseases could be at a higher risk of developing autoimmune hepatitis (AIH). So what challenges might occur when diagnosing patients with AIH? Learn more with Dr. Peter Buch as he discusses this with Dr. Alan Bonder, Director of Liver Transplantation at Beth Israel Deaconess Hospital and an Assistant Professor of Medicine at Harvard Medical School.

en

00:00:00

A Review of Autoimmune Hepatitis in Patients

GI Insights ·

2023/04/19

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Alan Bonder, MD Patients with underlying autoimmune diseases could be at a higher risk of developing autoimmune hepatitis (AIH). So what challenges might occur when diagnosing patients with AIH? Learn more with Dr. Peter Buch as he discusses this with Dr. Alan Bonder, Director of Liver Transplantation at Beth Israel Deaconess Hospital and an Assistant Professor of Medicine at Harvard Medical School.

en

00:00:00

Managing Patients with Lower Gastrointestinal Bleeding

GI Insights ·

2023/04/18

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Neil Sengupta, MD Lower GI bleeding is one of the most common reasons that patients are hospitalized due to a digestive disorder in the U.S.; however, there is little data available to help clinicians manage this condition in their patients. So how can we provide better care for these patients? Tune in with Dr. Peter Buch as he speaks with Dr. Neil Sengupta, Associate Professor of Medicine at the University of Chicago.

en

00:00:00

Managing Patients with Lower Gastrointestinal Bleeding

GI Insights ·

2023/04/18

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Neil Sengupta, MD Lower GI bleeding is one of the most common reasons that patients are hospitalized due to a digestive disorder in the U.S.; however, there is little data available to help clinicians manage this condition in their patients. So how can we provide better care for these patients? Tune in with Dr. Peter Buch as he speaks with Dr. Neil Sengupta, Associate Professor of Medicine at the University of Chicago.

en

00:00:00

Addressing Treatment Challenges in Hepatitis D Patients

GI Insights ·

2023/04/18

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Robert Wong, MD There may be benefit in testing all hepatitis B patients for hepatitis D, such as reducing the risk of disease progression and liver disease complications. So when should we be concerned about potential hepatitis D infection in our patients? Join Dr. Peter Buch as he discusses this with Dr. Robert Wong, Clinical Associate Professor at Stanford University.

en

00:00:00

Addressing Treatment Challenges in Hepatitis D Patients

GI Insights ·

2023/04/18

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Robert Wong, MD There may be benefit in testing all hepatitis B patients for hepatitis D, such as reducing the risk of disease progression and liver disease complications. So when should we be concerned about potential hepatitis D infection in our patients? Join Dr. Peter Buch as he discusses this with Dr. Robert Wong, Clinical Associate Professor at Stanford University.

en

00:00:00

Reviewing a Vibrating Capsule for Chronic Constipation

GI Insights ·

2023/04/12

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Eamonn Quigley, MD A new treatment option may help relieve chronic constipation in patients who might not respond well to traditional therapies. To learn more about a novel FDA-approved vibrating capsule, join Dr. Peter Buch as he speaks with Dr. Eamonn Quigley, the David M. Underwood Chair of Medicine in Digestive Disorders and a Professor of Medicine at Houston Methodist.

en

00:00:00

Reviewing a Vibrating Capsule for Chronic Constipation

GI Insights ·

2023/04/12

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Eamonn Quigley, MD A new treatment option may help relieve chronic constipation in patients who might not respond well to traditional therapies. To learn more about a novel FDA-approved vibrating capsule, join Dr. Peter Buch as he speaks with Dr. Eamonn Quigley, the David M. Underwood Chair of Medicine in Digestive Disorders and a Professor of Medicine at Houston Methodist.

en

00:00:00

Reviewing Management Strategies for Barrett’s...

GI Insights ·

2023/03/29

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Joel Rubenstein, M.D., M.Sc. Gastroesophageal reflux disease (GERD) is an important risk factor for Barrett’s esophagus and esophageal adenocarcinoma (EAC), but there are other important risk factors, such as gender and race. So is it time to look at alternative approaches to increase appropriate screenings? Join Dr. Peter Buch as he is joined by Dr. Joel Rubenstein, Research Scientist at the Kettles VA in Ann Arbor, Michigan and a

en

00:00:00

Assessing New Guidelines for Hepatocellular Carcinoma

GI Insights ·

2023/03/29

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Amit Singal, MD, MS Hepatocellular carcinoma (HCC) is the most common type of liver cancer and most often occurs in people with chronic liver disease. So should we be utilizing modalities other than standard ultrasound for routine early detection of HCC in cirrhotic patients? Listen to this discussion led by Dr. Peter Buch as he speaks with Dr. Amit Singal, Professor of Medicine and the Chief of Hepatology at the University of Texas

en

00:00:00

Assessing New Guidelines for Hepatocellular Carcinoma

GI Insights ·

2023/03/29

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Amit Singal, MD, MS Hepatocellular carcinoma (HCC) is the most common type of liver cancer and most often occurs in people with chronic liver disease. So should we be utilizing modalities other than standard ultrasound for routine early detection of HCC in cirrhotic patients? Listen to this discussion led by Dr. Peter Buch as he speaks with Dr. Amit Singal, Professor of Medicine and the Chief of Hepatology at the University of Texas

en

573 results

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事